Content
09/21/2022
Austin, TX USA
MicroTransponder
completed $73 million Series E Round funding. Investors include
USVP (lead), Green Park & Golf Ventures, Exceller Hunt, Osage University Partners, Action Potential Venture Capital, The Vertical Group.
About
MicroTransponder®, Inc. is a privately held, global medical device company based in Austin, Texas, committed to developing research-based neuroscience solutions. The company focuses on restoring dignity and function for people suffering from neurological conditions that impair sensory and motor function. MicroTransponder's FDA-approved Vivistim® Paired VNS™ System is a first-of-its-kind, clinically proven medical device that generates two to three times more improvement in upper limb function for chronic stroke survivors after six weeks of in-clinic occupational or physical therapy.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
